# Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis

> **NCT01164540** · PHASE3 · WITHDRAWN · sponsor: **AstraZeneca** · enrollment: 3000 (estimated)

## Conditions studied

- Venous Thrombosis
- Pulmonary Embolism

## Interventions

- **DRUG:** Rosuvastatin (AZD4522)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01164540
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-02
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 3000 (ESTIMATED)
- **Why stopped:** Due to discussion regarding the design of the study.
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01164540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01164540, "Study on the Effect of Rosuvastatin Treatment on the Prevention of Thrombosis in Patients With Previous Thrombosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01164540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*